<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>46</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effects of Immunocytokine Combined with Cattle Encephalon Glycoside and Ignotin on CTGF, HO-1 and NT-3 in Patients with Type 2 Diabetic Peripheral Neuropathy</title>
    <FirstPage>1632</FirstPage>
    <LastPage>1638</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Jianguo</FirstName>
        <LastName>SUN</LastName>
        <affiliation locale="en_US">People&#x2019;s Hospital of Rizhaolanshan, Rizhao, Shandong, PR China</affiliation>
      </Author>
      <Author>
        <FirstName>Hui</FirstName>
        <LastName>ZHENG</LastName>
        <affiliation locale="en_US">People&#x2019;s Hospital of Wulian, Rizhao, Shandong, PR China</affiliation>
      </Author>
      <Author>
        <FirstName>Xiuxia</FirstName>
        <LastName>QIN</LastName>
        <affiliation locale="en_US">People&#x2019;s Hospital of Rizhaolanshan, Rizhao, Shandong, PR China</affiliation>
      </Author>
      <Author>
        <FirstName>Liqin</FirstName>
        <LastName>QI</LastName>
        <affiliation locale="en_US">People&#x2019;s Hospital of Rizhaolanshan, Rizhao, Shandong, PR China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">&#xA0;Background: This study was designed to explore the correlation of connective tissue growth factor (CTGF), heme oxygenase (HO-1), neurotrophic factors (NT-3) with type 2 diabetic peripheral neuropathy, as well as the changes after immune cytokine alone and combined with cattleencephalon glycoside and ignotin treatment.

Methods: Seventy-six patients with type 2 diabetes and peripheral neuropathy charged into People&#x2019;s Hospital of Rizhaolanshan, China from 2014-2016 were selected. The severity of neuropathy was evaluated by TCSS. Pearson analysis was used to analyze the correlation between the degree of neuropathy and CTGF, HO-1 and NT-3. The patients were randomly divided into control group and observation group, n=38. The control group accepted TGF-&#x3B2;1 treatment on the basis of controlling diet and blood sugar, while the observation group was treated with cattle encephalon glycoside and ignotin injection on the basis of control group. CTGF&#x3001;HO-1, NT-3 concentration in the blood and nerve conductive velocity (NCV) were detected and analyzed before and after treatment.

Results: CTGF(r=-0.865), HO-1(r=-0.706), NT-3(r=-0.587) was negatively correlated with TCSS scores. After treatment, the concentrations of CTGF&#x3001;HO-1and NT-3 in the observation group were higher than the control group (P&lt;0.05). In moderate and severe lesions, the concentrations of CTGF, HO-1and NT-3 in the observation group were higher than the control group (P&lt;0.05). The conduction velocity of nerve increased with the increase of CTGF, HO-1 and NT-3 concentrations. The obvious effective rate and total effective rate of observation group were both higher than the control group.

Conclusion: &#xA0;Immune cytokine TGF-&#x3B2;1 combined with cattle encephalon glycoside and ignotin injection could improve the contents of CTGF, HO-1 and NT-3, and be better to treat the peripheral neuropathy of type 2 diabetes.

&#xA0;

&#xA0;</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/11758</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/11758/5842</pdf_url>
  </Article>
</Articles>
